Critical Colonoscopy Advancements Impact Results and Costs with Tim Moran Motus GI TRANSCRIPT
Download PDFMar 31, 2020
Tim Moran, CEO, Motus GI talks about their focus on endoscopy solutions that improve clinical outcomes for patients facing a critical colonoscopy while in the hospital. The Pure-Vu system developed by Motus GI is a disposable sleeve that fits on the top of their reusable scope to allow irrigation and suction...
Mar 31, 2020
Tim Moran, CEO, Motus GI talks about their focus on endoscopy solutions that improve clinical outcomes for patients facing a critical colonoscopy while in the hospital. The Pure-Vu system developed by Motus GI is a disposable sleeve that fits on the top of their reusable scope to allow irrigation and suction...
Mar 30, 2020
Greg Merril, CEO, Adaptive Phage Therapeutics describes useful viruses that host on and kill bacteria acting as nature's natural antibiotic. Phage therapy actually predates antibiotics but recent research has enabled scientist to better identify which phage will have the desired impact on specific bacteria. Greg talks...
Mar 30, 2020
Greg Merril, CEO, Adaptive Phage Therapeutics describes useful viruses that host on and kill bacteria acting as nature's natural antibiotic. Phage therapy actually predates antibiotics but recent research has enabled scientist to better identify which phage will have the desired impact on specific bacteria. Greg talks...
Novel Anti-Inflammatory Therapeutic Agent Showing Promise for Ulcerative Colitis with Dr. Hartmut Ehrlich Abivax TRANSCRIPT
Download PDFMar 24, 2020
Dr. Hartmut Ehrlich, CEO, Abivax gives an update of the French biotech's phase-2b clinical trial drug candidate ABX464 which has shown impressive results. Dr. Ehrlich discusses how this revolutionary small molecule for oral administration has shown strong anti-inflammatory effects to solve the unmet needs of patients...